Columbia L2M Accelerator Network:
Internal Life Science Accelerators
L2M Physical Science Accelerators
L2M Industry Programs
News and Announcements
July 15, 2024
Governor Hochul Announces Third Round of Biodefense Commercialization Fund Awards to Combat Infectious Disease Threats
To Date, More Than $25 Million Awarded to 11 Start-Ups and 16 Academic Institutions
$3 Million for Round Three Awardees Focusing on Rapid and Point-of-Care Diagnostics and Surveillance Tools
July 01, 2024
Columbia Lab-to-Market (L2M) Accelerator Network Publishes 2024 Annual Report
The Columbia Lab-to-Market (L2M) Accelerator Network serves as a framework to successfully develop, launch, and execute initiatives that help commercialize academic research.
Collectively, L2M programs have supported 672 faculty-led alumni teams in therapeutics, smart cities, diagnostics, AI, medical devices, and advanced materials over recent years, including granting 356 non-dilutive funding awards totaling over $51.6M!